This study aims to identify and explore novel therapeutic targets for combination therapy and immunomodulation in neuroblastoma, a pediatric tumor of the developing peripheral nervous system. The teams will collaboratively apply novel technology in functional cancer genetics, onco-immunology, animal modeling and liquid biopsy analysis. This program will yield novel therapeutic strategies with better survival and reduced adverse side effects.